Author argues Abbott Laboratories' earnings selloff is an overreaction given its wide moat and strong earnings, liking the stock at 13x PE.
ABT — LONG The author believes the recent earnings selloff in Abbott Laboratories is an overreaction, as a slight top-line miss does not change the company's wide moat and strong earnings beat. He cites personal use of their products and a 13x PE as reasons he likes the price here. The main risk implied is that the market may continue to punish the stock despite fundamentals.
I think the earnings sell off is an overreaction. A slight top line miss doesn’t really change the fact that this company has wide moat with strong earnings beat. My baby son use their products and I love the name. I like the price here with a 13x PE.
This Reddit post, published January 23, 2026, features u/anonymous_sheep1 discussing ABT. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/anonymous_sheep1 · Tickers: ABT